TCN-202: Phase I started

Theraclone began a double-blind, placebo-controlled, dose-escalation, U.S. Phase I trial to evaluate single and multiple doses of IV TCN-202 in up to 80 healthy volunteers. TCN-202 has Orphan Drug des...